Rhythm Pharmaceuticals
The Senior Manager, Drug Substance at Rhythm oversees CDMO project teams in the development and production of small molecule intermediates and APIs across all clinical stages. The role ensures processes meet regulatory and cGMP standards, manages technology transfers, and collaborates with vendors to deliver scalable, safe, and cost-effective manufacturing solutions.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2008
Rhythm Pharmaceuticals is a global biopharmaceutical company dedicated to transforming the lives of patients with rare neuroendocrine diseases by developing precision medicines that address the root cause. Its lead program, setmelanotide, targets the MC4R pathway to treat certain rare genetic forms of severe obesity and related neuroendocrine disorders. Rhythm advances therapies through clinical development and commercialization while partnering with clinicians, payers, and patient communities to expand access and support long‑term care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rhythm Pharmaceuticals.
24% above the average for this role
Senior Scientist I
Cytokinetics
Vice President, Drug Substance
BioCryst Pharmaceuticals
Process Chemistry Scientist
BioLife Plasma Services
Associate Scientific Director
Bristol Myers Squibb
Director, Technical Operations (Small Molecule Drug Substance)
MSD
Senior Manager, Process Development and Manufacturing
Assembly Bio